UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) October 30, 1995
CYTRX CORPORATION
(Exact name of registrant as specified in its charter)
Delaware 0-15327 58-1642740
(State or other jurisdiction (Commission (IRS Employer
of incorporation) File Number) Identification No.)
154 Technology Parkway, Norcross, Georgia 30092
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code (770) 368-9500
150 Technology Parkway, Norcross, Georgia 30092
(Former name or former address, if changed since last report)
Item 5 - Other Events
On October 30, 1995, CytRx Corporation announced that its Board of Directors
authorized the repurchase of up to 5 million shares of CytRx common stock.
Purchases may be made from time to time on the open market or in unsolicited
block transactions.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
CYTRX CORPORATION
(Registrant)
Date: October 30, 1995 By: /s/ Mark W. Reynolds
Mark W. Reynolds
Controller, Chief Accounting Officer
